MeSH tree: D27.505.696.422.750
Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be effective at treating and preventing substance-use disorders across all major addictive substances ...
Mar 4, 2026
0
43
Diabetes drugs that may soon be prescribed more widely in England could save thousands of lives each year, suggests a new study led by researchers at the London School of Hygiene & Tropical Medicine (LSHTM) and UCL. Using ...
Feb 10, 2026
0
16
A group of medications often used to treat diabetes may also help protect aging kidneys, according to a new study.
Feb 7, 2026
0
10
Gout, a type of inflammatory arthritis caused by a buildup of uric acid (urate) in the body, affects 5.1% of U.S. adults (over 12 million), including 10% of those aged 65 or older. Urate is produced by the body when breaking ...
Feb 3, 2026
0
10
In a new study published in Kidney International, researchers report that drugs known as SGLT2 inhibitors prevented age-related deterioration of kidney structure and function in the African turquoise killifish, a vertebrate ...
Jan 26, 2026
0
13
A study led by the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), in collaboration with the University of Hong Kong–Shenzhen Hospital, has demonstrated ...
Jan 20, 2026
0
8
A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors have a slightly lower risk of developing diabetic foot problems compared ...
Jan 5, 2026
0
10
A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new study says.
Jan 5, 2026
0
22
Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical utility study demonstrating that the PromarkerD blood test provides actionable information that significantly ...
Dec 22, 2025
0
15
For individuals with advanced chronic kidney disease (CKD), angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) treatment is associated with a reduced risk for kidney failure with replacement ...
Jul 8, 2024
0
39
